Commodore Capital
$1.7B Assets Reported
46 Holdings
Latest filing 2026-03-31
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| RLAY | RELAY THERAPEUTICS INC | 17,000,000 | $169M | 9.8% |
| ALKS | ALKERMES PLC | 4,200,000 | $149M | 8.6% |
| ELVN | ENLIVEN THERAPEUTICS INC | 3,275,000 | $128M | 7.4% |
| COGT | COGENT BIOSCIENCES INC | 2,888,007 | $111M | 6.4% |
| SYRE | SPYRE THERAPEUTICS INC | 1,912,380 | $96M | 5.6% |
| TYRA | TYRA BIOSCIENCES INC | 2,475,000 | $95M | 5.5% |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 2,696,616 | $86M | 4.9% |
| NUVL | NUVALENT INC | 833,600 | $85M | 4.9% |
| AMLX | AMYLYX PHARMACEUTICALS INC | 5,650,000 | $79M | 4.5% |
| KYMR | KYMERA THERAPEUTICS INC | 750,000 | $62M | 3.6% |
Track Commodore Capital's 13F portfolio: $1.7B in reported holdings, 46 positions. Top holdings, AUM, and quarterly changes on SentiSense.